From Patanjali's claim to U-turn on Coronil: Sequence of events

Patanjali Launches Ayurvedic Drug For Covid-19

1 / 8
The launch of Coronil at Haridwar

On June 23, Baba Ramdev-led Patanjali Ayurved launched a medicine, 'Coronil', for treating Covid-19 in just seven days. Acharya Balkrishna, Chief Executive Officer (CEO) of Patanjali, had earlier this month claimed that an Ayurvedic medicine developed by the company has been able to cure Covid-19 patients within 5-14 days.

ASCI flags 50 ad campaigns by Ayurveda Offering Covid-19 Cure

2 / 8

The Advertising Standards Council of India (ASCI) has said it has found 50 campaigns by Ayurveda and homeopathic drug makers offering cure for Covid-19 in April alone, and had flagged them to the union government for action. The advertisements were across media platforms and were found to be violating Ministry of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) order dated April 1, 2020, prohibiting publicity and advertisement of AYUSH-related claims, the self-regulatory body said in a statement.

AYUSH Ministry frowns and asks for details

3 / 8
Shripad Naik, AYUSH Ministry

The claim by Patanjali Ayurved to have discovered a medicine that could cure coronavirus was scoffed at by the AYUSH Ministry. AYUSH Ministry asked the company to stop advertisements for the drug until the issue had been examined. The AYUSH Ministry also sought a detailed report on composition, testing and other data of the drug. The Centre had barred the firm from advertising the products after Ramdev said they cured 280 patients within days in trials.  

Will take action against sale of Patanjali Covid-19 drug in Rajasthan: Govt

4 / 8
Rajasthan Health Minister Raghu Sharma

Rajasthan government on June 24 clarified that this drug cannot be not used as a medicine in the state without the permission of the Ministry of AYUSH. Neither has anyone applied to the state government nor has the state government given any permission in this regard, State Rajasthan Health Minister Raghu Sharma said.

Ramdev's Patanjali insists it broke no regulations

5 / 8
S K Tijarawala's Tweet

Patanjali Ayurved on June 25 insisted that it broke no law. "There is no room for confusion," the herbal products company said in a tweet. “The licence for the drug was obtained on the basis of the traditional knowledge and experience related to the medicinal virtues of Ashwagandha, Giloy and Tulsi," Patanjali spokesperson S K Tijarawala said.

Rajasthan cops charge Ramdev, Patanjali MD with cheating for Covid-19 drug

6 / 8
Rajasthan Police

The Rajasthan Police on June 27 lodged an FIR against yoga guru Ramdev for allegedly launching an Ayurvedic drug for treating Covid-19 without regulatory approval, a senior officer said. Four others MD of Ramdev-promoted Patanjali Ayurved Acharya Balkrishna; Director of National Institute of Medical Sciences and Research (NIMS), Jaipur, B S Tomar; his son Anurag Tomar; and senior scientist Anurag Varshney have also been named in the FIR, he said.

Patanjali takes a u-turn; says never claimed to have made Covid-19 medicine

7 / 8
Acharya Balakrishna, CEO, Patanjali Ayurved

On June 30 Patanjali Ayurved said that it never claimed to have made medicine for coronavirus.The Haridwar-based organisation has withdrawn from its earlier claim, in reply to the notice given by Uttarakhand Ayush Ministry."Patanjali has never claimed to make corona medicine. Rather, corona patients have been cured with this medicine. The drug was made under the license issued by the Ayush Ministry," stated the reply by Patanjali Ayurved CEO Acharya Balakrishna to the notice. "We made the combination of Tulsi Giloy Ashwagandha at an advanced level and when the clinical trials were done on the patients of Covid-19, the coronavirus patients were cured. A conspiracy has been hatched against us and if the Ayush Ministry tells us to conduct clinical trials once again then we are ready to face it," he added.

Now, Patanjali can sell its drug, but not as a cure for Covid-19

8 / 8
Patanjali coronil tablet


Yoga guru Ramdev's Patanjali Ayurved on July 1 said there are no AYUSH Ministry restrictions on selling Coronil, a drug the company recently launched as a medicine for Covid-19 but is now calling it a product to manage the disease. The Union ministry confirmed that Patanjali can sell the product but not as a cure for Covid-19.

AYUSH Ministry has only given permission to sell this particular formulation as immunity booster and not as a medicinal cure for Covid-19, it said. At a press conference in Haridwar, Ramdev claimed the ministry has said that Patanjali did an an appropriate job for Covid-19 management.


Read our full coverage on Patanjali Ayurved

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel








Related News

Most Read


[ more ]


[ more ]


[ more ]

Latest News

[ more ]

Todays Paper

[ more ]

News you can use

[ more ]